Trial Profile
Phase I Study to Evaluate Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2019
Price :
$35
*
At a glance
- Drugs Fosfomycin tromethamine (Primary)
- Indications Urinary tract infections
- Focus Adverse reactions; Pharmacokinetics
- Acronyms PROOF
- 11 Jun 2018 Results evaluating PK, safety and tolerability published in the Antimicrobial Agents and Chemotherapy
- 08 Oct 2017 Results evaluating safety and tolerability of two dosing regimens of Fosfomycin-tromethamine in healthy adult subjects presented at the IDWeek 2017
- 08 Oct 2017 Results presented at the IDWeek 2017